Main Menu
Search
Close this search box.
Donate
Sign Up

Viral risk factors in ME/CFS

Study Aim

This project aims to characterize viral factors associated with immune responses and inflammation in ME/CFS.

Investigators

  • Dawei Li, PhD
  • Ronald Davis, PhD

Updates and Potential

  • IRB/Ethics approval completed.

  •  Samples are all collected.

  • Data collection complete and analysis nearly complete.

  • Paper drafting has begun but waiting for more guidance on data analysis workflow.

  • Another 3 months needed until paper submission.

STUDY HYPOTHESIS AND DESCRIPTION

Viral triggers of immune response in ME/CFS have long been speculated but remain poorly understood. Germline endogenous retroviruses (ERVs) and somatic viral infections both have significant impacts on immune response and have been studied for years; however, the previous studies mainly focused on commonly tested viral pathogens or several known ERV candidates. Not surprisingly, none has been proven to be common to ME/CFS patients. A comprehensive analysis of the full spectrum of ERVs and the virome is likely to change our understanding of the roles of ERVs and viral infections in ME/CFS. This proposal is aimed to develop novel algorithms to investigate the contributions of genome-wide ERVs and the human virome to ME/CFS.

OBJECTIVES

Two young intercultural professionals in whitecoats discussing microchip scheme while one of them pointing at computer screen

  1. Investigate somatic viral infections (such as the human virome and virome-wide viral infections) and germline viral sequences (such as endogenous retrovirus variants) in patient genomes.
  2. Develop the analytic methods based on a novel algorithm and apply it to the pilot dataset from ME/CFS patients.
  3. Identify viral factors associated with ME/CFS and/or related phenotypes.

Other links you might be interested in:

The End ME / CFS Project
University of Montreal Collaborative Research Center
Facebook Twitter Youtube Instagram Linkedin

OMF is a non-profit 501(c)(3) organization
(EIN# 26-4712664). All donations are tax-deductible to the extent allowed by law.

Open Medicine Foundation®
29302 Laro Drive,  Agoura Hills, CA 91301 USA
Phone: 650-242-8669
info@omf.ngo

Contact Us

PRIVACY  |  COOKIE   |   CONSENT   |  MEDICAL & OTHER DISCLAIMERS

Copyright © 2024 Open Medicine Foundation. All Rights Reserved.

Consent management

Consent Preferences

Data Subject Access Request (DSAR) Form 

Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (ME / CFS) Post Treatment Lyme Disease Syndrome (PTLDS), Fibromyalgia Leading Research. Delivering Hope.Open Medicine Foundation®

What are the advantages of giving from your Donor Advised Fund (DAF)?

  • Your gifts to your donor advised fund entitle you to an immediate income tax deduction at the time of contribution.
  • You avoid capital gains tax on appreciated assets you place in your donor advised fund.
  • Your fund’s investment gains accumulate tax free.
  • Funds are distributed to Open Medicine Foundation in your name and immediately put to use to support our worldwide research efforts.


How do I make a donation through my DAF?

Just click on the DAF widget below. It is simple and convenient to find your fund among the over 900 funds in our system.

Still can’t find your fund? 

  • Request a grant distribution through your Donor Advised Fund sponsor
  • Be sure to use OMF’s EIN #26-4712664
  • You can also designate OMF as a beneficiary for your Donor Advised Fund
  • Questions? Give us a call at 650-242-8669 
Give now from your
Donor-Advised Fund
 
Donate